On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective.
Viceconti M, Tome M, Dartee W, Knezevic I, Hernandez Penna S, Mazzà C, Caulfield B, Garcia-Aymerich J, Becker C, Maetzler W, Troosters T, Sharrack B, Davico G, Corriol-Rohou S, Rochester L; Mobilise-D Consortium.
Viceconti M, et al. Among authors: mazza c.
Front Med (Lausanne). 2022 Sep 21;9:996903. doi: 10.3389/fmed.2022.996903. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36213641
Free PMC article.